| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10175759 | Journal of Orthopaedic Science | 2010 | 9 Pages |
Abstract
In this study, we utilized IP-CHA as a bone substitute after curettage of benign bone tumors and demonstrated its usefulness in the clinical situation. IP-CHA comparatively exhibited excellent bone formation at an early stage although the problem of recurrence of the tumor remained. We conclude that IP-CHA is a useful bone substitute for the treatment of benign bone tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Noriyuki Tamai, Akira Myoui, Ikuo Kudawara, Takafumi Ueda, Hideki Yoshikawa,